Onelife Capital Advisors Limited has announced a significant change in its key managerial personnel with the resignation of its Interim Chief Financial Officer. The company has informed stock exchanges about this development in compliance with regulatory requirements.

Leadership Transition Details

Mr. Pandoo Prabhakar Naig has resigned from his position as Interim Chief Financial Officer of Onelife Capital Advisors Limited, effective from the closing of business hours on January 20, 2026. The resignation was submitted due to pre-occupation and personal reasons, with the executive confirming that there are no material reasons for his departure beyond those mentioned.

Regulatory Compliance

The company has fulfilled its obligations under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, by promptly notifying both major stock exchanges. The intimation was filed with BSE Limited (Scrip Code: 533632) and National Stock Exchange of India Limited (Symbol: ONELIFECAP) on January 20, 2026.

The resignation letter submitted by Mr. Naig explicitly confirms that there are no material reasons for his resignation other than the pre-occupation and personal reasons stated. This disclosure aligns with the requirements of Regulation 30 read with Schedule III, Para A, of SEBI regulations.

Executive's Farewell Message

In his resignation letter addressed to the Board of Directors, Mr. Naig expressed sincere appreciation for the opportunities and trust extended to him during his tenure with the company. He specifically requested the Board to:

• Accept his resignation with effect from closing of business hours on January 20, 2026
• Make necessary filings with the Registrar of Companies, Mumbai
• Relieve him from his duties and responsibilities accordingly

The departing CFO concluded his communication by wishing Onelife Capital Advisors Limited continued growth and success in the future, maintaining a positive tone despite his departure.

Company Operations

Onelife Capital Advisors Limited, incorporated under CIN L74140MH2007PLC173660, operates from its registered office at Plot No. A 356, Road No. 26, Wagle Industrial Estate, MIDC, Thane (W) - 400604. The company maintains its corporate communications through established channels and continues its business operations following standard succession protocols for key managerial positions.

Onelife Capital Advisors Limited has successfully concluded its board meeting held on December 10, 2025, with significant approvals that will impact the company's capital structure and business expansion plans. The board has given its approval for a rights issue of up to ₹30.00 crores and other strategic initiatives, as communicated to BSE Limited and National Stock Exchange of India Limited.

Board Meeting Outcomes

The key decisions taken during the board meeting are outlined below:

Rights Issue Committee Meeting Scheduled

Following the board's approval, the company has scheduled a Rights Issue Committee meeting for December 17, 2025, to be conducted through video conferencing. The meeting will focus on finalizing the specific terms of the rights issue that were initially approved by the board.

Rights Issue Terms to be Finalized

The Rights Issue Committee meeting will address several critical aspects of the ₹30.00 crore fundraising initiative. The committee will determine the rights issue price and related payment mechanism, rights entitlement ratio, record date, and timing of the rights issue.

The detailed terms of the rights issue, including issue price, rights entitlement ratio, record date, timing, and terms of payment, will be determined in due course by the Board or Rights Issue Committee in accordance with applicable laws and subject to receipt of necessary approvals including in-principle approval from stock exchanges.

Rights Issue Committee Composition

To oversee the rights issue process, the board has constituted a Rights Issue Committee with the following composition:

This committee will handle the issue, offer, and allotment of equity shares and other matters in connection with or incidental to the rights issue.

Trading Window and Regulatory Compliance

In compliance with SEBI regulations, the company has announced the closure of the trading window for dealing in securities from December 12, 2025, until 48 hours after the conclusion of the Rights Issue Committee meeting on December 17, 2025. This measure ensures compliance with insider trading regulations during the decision-making process.

All approvals remain subject to receipt of statutory and regulatory approvals in accordance with the amended SEBI regulations and other applicable frameworks. The company continues to maintain compliance with all necessary regulatory requirements for the proposed corporate actions.